Kevin N. Dietz Ph.D.

Patent Agent

New Orleans
T: 504.566.5241
F: 504.585.6941

Dr. Kevin Dietz is a registered patent agent in the Firm's New Orleans office and is also a member of the Firm's Intellectual Property Group.

Professional Biography

Dr. Dietz concentrates his practice on U.S. patent prosecution for life science and biotechnology fields, patent portfolio management and patentability assessment.

Prior to joining Baker Donelson, Dr. Dietz was with the Office of Technology Management at LSU Health Sciences Center New Orleans, where he focused on technology evaluation and marketing, patentability assessment and patent portfolio management.

Prior to joining LSU Health Sciences Center, Dr. Dietz completed a joint post-doctoral fellowship in the Department of Neurology at Harvard Medical School and the Center for Human Genetic Research at Massachusetts General Hospital, where he investigated the role of epigenetic modifications in Huntington's disease in the laboratory of Dr. James Gusella. He graduated from Louisiana State University with an undergraduate degree in Biology, and received a Ph.D. in Genetics from LSU Health Sciences Center.

Dr. Dietz's technical skills encompass genetics, biochemistry, molecular biology and cell biology. The author and co-author of several publications, he has also presented both oral presentations and posters at scientific meetings and conferences.

Member – Association of University Technology Managers
- Committee Member, Leadership Development Committee
- Co-chair, Membership Development Committee
Member – Gulf Coast Intellectual Property Association
Recipient – 2015 AUTM Volunteer Service Award, Western Hemisphere

Antibodies, protein therapeutics, gene therapy, vaccines, RNA-based therapeutics, stem cell technologies, and treatments and diagnostics for cancer, neurodegenerative diseases, infectious diseases, ocular diseases and inflammation.

"SUCCESS Act Extends USPTO's Fee-Setting Authority," IAM Weekly International Report (December 2018)
"Tribal Sovereign Immunity Does Not Apply to PTAB Proceedings," IAM Weekly International Report (March 2018)
"Potential Shift in Landscape of University IP Management," IAM Weekly International Report (December 2017)
"When Big Brother Comes Marching In: Patent Challenges on Entrepreneurial Campuses," IPWatchdog® (November 2017)
Lead Author – "Public Universities are Immune from Inter Partes Review, but are Their Patent Co-Owners?," IAM Weekly International Report (August 2017)
Lead Author – "Is it time to reform 35 USC Section 101?," IAM Weekly International Report (June 2017)
Lead Author – "PTAB: Public Universities Immune to Inter Partes Review," IAM Weekly International Report (April 2017)
Lead Author – "The Federal Government's March-In Right: What Does it Mean for Your Intellectual Property?," IAM Weekly International Report (December 2016)
Lead Author – "USPTO Requests Public Comment on Proposed Fee Adjustments," IAM Weekly International Report (October 2016)
Lead Author – "The Drosophila Huntington's disease gene ortholog dhtt influences chromatin regulation during development," Human Molecular Genetics (January 2015)
Lead Author – "Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation," International Journal of Biochemistry & Cell Biology (June 2011)

Panelist – "Get the 411 on a Gig in Tech Transfer," 2019 AUTM Annual Meeting, Austin, Texas (February 2019)
Moderator – "New to Tech Transfer?," 2019 AUTM Annual Meeting, Austin, Texas (February 2019)
"§101 Woes and Solution," Dana-Farber Cancer Institute, Boston, Massachusetts (November 2018)
"Intellectual Property: A Building Block to a Successful Business," Arkansas State University, Jonesboro, Arkansas (November 2018)
"Technology Commercialization: A synergy between Science, Business and Law," LSU Health Sciences Center (April 2018)
Responsible Conduct of Research Seminar on Intellectual Property, Pennington Biomedical Research Center (April 2018)
Moderator – "New to Tech Transfer?," 2018 AUTM Annual Meeting, Phoenix, Arizona (February 2018)
Moderator – Biotech & Cannabis Industry Panel, Turnaround Management Association of Louisiana (November 2017)
"Partnering with Universities and Industry," 2017 Louisiana Life Sciences and Technology Symposium, New Orleans, Louisiana (September 2017)
Moderator – "New to Tech Transfer?," 2017 AUTM Annual Meeting, Hollywood, Florida (March 2017)
"Critical Issues in Licensing University Technologies," New Orleans BioInnovation Center (August 2016)
"University Patent Applications: To Be or Not To Be…a 'Micro Entity'," Network of Technology Transfer Professionals of Louisiana (NTTPL) (July 2016)

Practices

Industries

Education

Harvard Medical School, Department of Neurology; Massachusetts General Hospital, Center for Human Genetics Research
- Research Fellow, 2010 – 2013
LSU Health Sciences Center New Orleans, Ph.D. in Genetics, 2010
Louisiana State University, BS in Biology, 2005

Admissions

United States Patent and Trademark Agent, Registration Number 73,511

Featured Media

Patent Trial and Appeal Board Proceedings: Friend or Foe?

Webinar / April 23, 2018

Managing University Patents: Discussion of Legal Issues Commonly Faced by University Administrators

Webinar / June 20, 2017

Search By Last Name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Baker Donelson is a national law firm with more than 650 attorneys and public policy advisors representing more than 30 practice areas to serve a wide range of legal needs. Clients receive knowledgeable guidance from experienced, multi-disciplined industry and client service teams, all seamlessly connected across 24 offices in Alabama, Florida, Georgia, Louisiana, Maryland, Mississippi, North Carolina, South Carolina, Tennessee, Texas, Virginia, and Washington, D.C.